JPRN-UMIN000011169已完成未知
Effect of EPA/DHA supplementation added on DPP4 inhibitors on lipid and glucose metabolism in patients with type 2 diabetes - Effect of EPA/DHA supplementation added on DPP4 inhibitors on lipid and glucose metabolism
Department of Internal Medicine, Keio University School of Medicine0 个研究点目标入组 50 人开始时间: 2013年8月1日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 50
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1) Patients with a history of hypersensitivity to omega-3 fatty acids ethyl 2) Patients who are bleeding (Hemophilia, capillary fragility, gastrointestinal ulcers, urinary tract bleeding, hemoptysis, vitreous hemorrhage, etc.) 3) Patients with severe ketosis or diabetic coma/pre-coma 4) Patients with severe infection, trauma or perioperative period
研究者
相似试验
已完成
不适用
Effects of concomitant administration of DPP-4 and SGLT2 inhibitors in Japanese patients with type 2 diabetesType 2 diabetesJPRN-UMIN000026442agoya University220
已完成
不适用
Investigation of pleiotropic effect of DPP-4 inhibitor, sitagliptin for type 2 diabetic patients with old myocardial infarctiotype 2 diabetic patients with old myocardial infarctionJPRN-UMIN000012562Department of Cardiology and Nephrology, Mie University Graduate School of Medicine, MUSIC FAIR Project Office30
招募中
不适用
Investigation of the impact of DPP-4 inhibition on serum brain natriuretic peptide level of diabetic patients with congestive heart failure.JPRN-UMIN000015685Mitsui Memorial Hospital50
进行中（未招募）
1 期
Effects of linagliptin on left ventricular myocardial DYsfunction in patients with type 2 DiAbetes mellitus.Type 2 Diabetes mellitusMedDRA version: 17.1Level: HLGTClassification code 10018424Term: Glucose metabolism disorders (incl diabetes mellitus)System Organ Class: 10014698 - Endocrine disordersMedDRA version: 17.1Level: PTClassification code 10067585Term: Type 2 diabetes mellitusSystem Organ Class: 10027433 - Metabolism and nutrition disordersMedDRA version: 17.1Level: SOCClassification code 10027433Term: Metabolism and nutrition disordersSystem Organ Class: 10027433 - Metabolism and nutrition disordersMedDRA version: 17.1Level: HLTClassification code 10012602Term: Diabetes mellitus (incl subtypes)System Organ Class: 10014698 - Endocrine disordersEUCTR2014-004683-38-ITFondazione per il Tuo cuore onlus-ANMCO186
已完成
不适用
The effects of the combination therapy of DPP-4 inhibitor alogliptin and alfa-glucosidase inhibitor on markers of inflammation and oxidative stress - comparison between Acarbose and Voglibosetype 2 diabetes mellitusJPRN-UMIN000007714Department of Internal Medicine, School of Medicine, Keio University40